{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:41:14Z","timestamp":1792269674865,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"DOI":"10.7759\/cureus.114025","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:17:13Z","timestamp":1785961033000},"source":"Crossref","is-referenced-by-count":1,"title":["Utility of the Inflammatory Bowel Disease Serology, Genetics, and Inflammation (IBD-SGI) Panel in the Evaluation of Atypical Ulcerative Colitis With Active Nonsteroidal Anti-Inflammatory Drug Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Landys Z","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003463","article-title":"ACG clinical guideline update: ulcerative colitis in adults","volume":"120","author":"Rubin DT","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025, 120:1187-224. 10.14309\/ajg.0000000000003463","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy140","article-title":"The IBD SGI diagnostic test is frequently used by non-gastroenterologists to screen for inflammatory bowel disease","volume":"24","author":"Berinstein JA","year":"2018","unstructured":"Berinstein JA, Waljee AK, Stidham RW, Higgins PD, Govani SM. The IBD SGI diagnostic test is frequently used by non-gastroenterologists to screen for inflammatory bowel disease. Inflamm Bowel Dis. 2018, 24:e18. 10.1093\/ibd\/izy140","journal-title":"Inflamm Bowel Dis"},{"key":"ref3","unstructured":"Centers for Medicare & Medicaid Services. MolDX: Prometheus\u00ae IBD sgi Diagnostic\u00ae policy (L37539). Medicare Coverage Database. (2024). Accessed: June 12, 2026: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02629.x","article-title":"Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease","volume":"16","author":"Tanaka M","year":"2001","unstructured":"Tanaka M, Saito H, Kusumi T, et al.. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol. 2001, 16:1353-9. 10.1046\/j.1440-1746.2001.02629.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-14-93","article-title":"Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children","volume":"14","author":"Simmonds N","year":"2014","unstructured":"Simmonds N, Furman M, Karanika E, Phillips A, Bates AW. Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children. BMC Gastroenterol. 2014, 14:93. 10.1186\/1471-230X-14-93","journal-title":"BMC Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12242","article-title":"Gut inflammation induced by drugs: can pathology help to differentiate from inflammatory bowel disease?","volume":"10","author":"Herlihy N","year":"2022","unstructured":"Herlihy N, Feakins R. Gut inflammation induced by drugs: can pathology help to differentiate from inflammatory bowel disease?. United European Gastroenterol J. 2022, 10:451-64. 10.1002\/ueg2.12242","journal-title":"United European Gastroenterol J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000373","article-title":"Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation","volume":"7","author":"Alhmoud T","year":"2020","unstructured":"Alhmoud T, Gremida A, Colom Steele D, et al.. Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation. BMJ Open Gastroenterol. 2020, 7:e000373. 10.1136\/bmjgast-2020-000373","journal-title":"BMJ Open Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.06.018","article-title":"NSAID-induced colopathy","volume":"96","author":"Kamboj AK","year":"2021","unstructured":"Kamboj AK, Moreira RK, Sweetser S. NSAID-induced colopathy. Mayo Clin Proc. 2021, 96:2724-5. 10.1016\/j.mayocp.2021.06.018","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1468457","article-title":"Exploring genetic structures and shared sites between alcohol, cheese intake, and inflammatory bowel disease","volume":"12","author":"Huang Z","year":"2025","unstructured":"Huang Z, Yuan W. Exploring genetic structures and shared sites between alcohol, cheese intake, and inflammatory bowel disease. Front Nutr. 2025, 12:1468457. 10.3389\/fnut.2025.1468457","journal-title":"Front Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14309\/01.AJG.0000777076.99515.8B","article-title":"S886 chronic nonsteroidal anti-inflammatory drug use and its association with microscopic colitis and inflammatory bowel disease: a retrospective case-control study","volume":"116","author":"Haider M","year":"2021","unstructured":"Haider M, Ahmed FS, Nadeem M, Malik A, Ismail R, Hettiarachichi M. S886 chronic nonsteroidal anti-inflammatory drug use and its association with microscopic colitis and inflammatory bowel disease: a retrospective case-control study. Am J Gastroenterol. 2021, 116:S416-7. 10.14309\/01.AJG.0000777076.99515.8B","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.11.037","article-title":"Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDS with inflammatory bowel disease: results from the Prospective Urban Rural Epidemiology (PURE) study","volume":"21","author":"Narula N","year":"2023","unstructured":"Narula N, Wong EC, Pray C, et al.. Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDS with inflammatory bowel disease: results from the Prospective Urban Rural Epidemiology (PURE) study. Clin Gastroenterol Hepatol. 2023, 21:2649-59.e16. 10.1016\/j.cgh.2022.11.037","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20863","article-title":"Factors associated with delayed diagnosis of Crohn's disease: a systematic review and meta-analysis","volume":"9","author":"Xie J","year":"2023","unstructured":"Xie J, Chen M, Wang W, Shao R. Factors associated with delayed diagnosis of Crohn's disease: a systematic review and meta-analysis. Heliyon. 2023, 9:e20863. 10.1016\/j.heliyon.2023.e20863","journal-title":"Heliyon"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation","volume":"47","author":"Moninuola OO","year":"2018","unstructured":"Moninuola OO, Milligan W, Lochhead P, Khalili H. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther. 2018, 47:1428-39. 10.1111\/apt.14606","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu17091514","article-title":"NSAIDs, ileal inflammation, and glucose metabolism: insights from a large retrospective cohort","volume":"17","author":"Rodriguez SH","year":"2025","unstructured":"Rodriguez SH, Hoilat GJ, Pradhan N, Gonzalez Bravo C, Correia ML, Mokadem M. NSAIDs, ileal inflammation, and glucose metabolism: insights from a large retrospective cohort. Nutrients. 2025, 17:1514. 10.3390\/nu17091514","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor B","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011, 474:307-17. 10.1038\/nature10209","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.146357","article-title":"C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study","volume":"57","author":"Henriksen M","year":"2008","unstructured":"Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008, 57:1518-23. 10.1136\/gut.2007.146357","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01229-8","article-title":"Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission","volume":"20","author":"Wakai M","year":"2020","unstructured":"Wakai M, Hayashi R, Tanaka S, et al.. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission. BMC Gastroenterol. 2020, 20:85. 10.1186\/s12876-020-01229-8","journal-title":"BMC Gastroenterol"},{"key":"ref18","unstructured":"Providence Health Plan. Serologic testing and therapeutic monitoring for inflammatory bowel disease. Medical Policy No. 218. (2025). Accessed. June 12, 2026: https:\/\/www.providencehealthplan.com\/-\/media\/providence\/website\/pdfs\/providers\/medical-policy-and-provider-informatio...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/507621-utility-of-the-inflammatory-bowel-disease-serology-genetics-and-inflammation-ibd-sgi-panel-in-the-evaluation-of-atypical-ulcerative-colitis-with-active-nonsteroidal-anti-inflammatory-drug-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:17:15Z","timestamp":1785961035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/507621-utility-of-the-inflammatory-bowel-disease-serology-genetics-and-inflammation-ibd-sgi-panel-in-the-evaluation-of-atypical-ulcerative-colitis-with-active-nonsteroidal-anti-inflammatory-drug-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.114025","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}